5-hydroxymethylcytosine has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agirre, X; Alvarez, S; Boultwood, J; Calasanz, MJ; Cross, NC; Cruz Cigudosa, J; Delabesse, E; Fernandez-Mercado, M; Garate, L; Martín-Subero, JI; Martínez-Calle, N; Pérez, C; Prósper, F; Rifon, J; Segura, V; Varea, S; Wainscoat, JS | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia.
Topics: 5-Methylcytosine; Computational Biology; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Humans; Isocitrate Dehydrogenase; Janus Kinase 2; Leukemia, Myelomonocytic, Chronic; Mutation; Oligonucleotide Array Sequence Analysis; Polycomb Repressive Complex 2; Proto-Oncogene Proteins; Transcription Factors | 2012 |